NDA 215315 describes MEXILETINE HYDROCHLORIDE, which is a drug marketed by
Ani Pharms,
Annora Pharma,
Crossmedika Sa,
Leading,
Novast Labs,
Senores Pharms,
Teva,
Watson Labs, and
Zenara, and is included in ten NDAs. It is available from
fourteen suppliers. Additional details are available on the
MEXILETINE HYDROCHLORIDE profile page.
The generic ingredient in MEXILETINE HYDROCHLORIDE is
mexiletine hydrochloride. There are five
drug master file entries for this compound. Fourteen
suppliers are listed for this compound. Additional details are available on the
mexiletine hydrochloride profile page.